Evanthia Anadioti1, W Day Gates2, Julie Elpers3, Ingeborg J De Kok4, Lyndon F Cooper5. 1. Assistant Professor, Clinical Restorative Dentistry, Department of Preventive and Restorative Sciences, University of Pennsylvania School of Dental Medicine, Philadelphia, Penn. Electronic address: evanad@upenn.edu. 2. Private practice, Mobile, Ala; and Adjunct Assistant Professor, Department of Prosthodontics, University of North Carolina School of Dentistry, Chapel Hill, NC. 3. Private practice, Boston, Mass; and Adjunct Assistant Professor, Department of Prosthodontics, University of North Carolina School of Dentistry, Chapel Hill, NC. 4. Associate Professor, Department of Prosthodontics, University of North Carolina School of Dentistry, Chapel Hill, NC. 5. Associate Dean for Research; Head, Department of Oral Biology, University of Illinois at Chicago, College of Dentistry, Chicago, Ill.
Abstract
STATEMENT OF PROBLEM: Implant therapy involving an unsplinted 2-implant-retained overdenture is well defined as a successful treatment for a patient with an edentulous mandible. However, a similar unsplinted implant therapy supporting a maxillary overdenture is not well characterized. PURPOSE: The purpose of this retrospective study was to evaluate maxillary overdentures retained by 4 unsplinted implants measuring implant survival, overdenture survival, and patient-reported outcomes. MATERIAL AND METHODS: Participants who had received an unsplinted implant-retained maxillary overdenture were included in the study. Participants presented for one denture recall appointment, during which comprehensive examination, including radiographs, was performed and clinical findings were recorded. Participants also completed the Oral Health Impact Profile-49 (OHIP-49) and a 20-item visual analog scale (VAS) satisfaction questionnaire. Nonparametric statistical tests were used to compare OHIP-49 and VAS scores across age, sex, time since overdenture insertion, mandibular dental status, smoking status, maxillary mucosal health, and overdenture hygiene. RESULTS: For the 44 participants, 3 of 4 implants failed in 1 individual. The cumulative implant survival rate was 98% (97.7% patient level). No prosthetic failures (that is, overdenture replacement) occurred, indicating a 100% prosthesis survival rate. The mean ±standard deviation OHIP-49 severity score was 23.6 ±26.0, and the mean ±standard deviation total VAS score was 179.2 ±29.4. Increased age was associated with lower OHIP-49 severity score (P=.036), and participants with unhealthy oral mucosa or denture stomatitis demonstrated significantly higher OHIP-49 severity scores (P=.003). CONCLUSIONS: In this retrospective evaluation, unsplinted implant-retained maxillary overdenture therapy was associated with high implant and prosthetic survival, as well as high patient satisfaction and quality of life. Age, sex, maxillary mucosal health, and mandibular dental status resulted in significant differences with respect to oral health-related quality of life and patient satisfaction, indicating that this treatment option may be ideal for certain patients.
STATEMENT OF PROBLEM: Implant therapy involving an unsplinted 2-implant-retained overdenture is well defined as a successful treatment for a patient with an edentulous mandible. However, a similar unsplinted implant therapy supporting a maxillary overdenture is not well characterized. PURPOSE: The purpose of this retrospective study was to evaluate maxillary overdentures retained by 4 unsplinted implants measuring implant survival, overdenture survival, and patient-reported outcomes. MATERIAL AND METHODS:Participants who had received an unsplinted implant-retained maxillary overdenture were included in the study. Participants presented for one denture recall appointment, during which comprehensive examination, including radiographs, was performed and clinical findings were recorded. Participants also completed the Oral Health Impact Profile-49 (OHIP-49) and a 20-item visual analog scale (VAS) satisfaction questionnaire. Nonparametric statistical tests were used to compare OHIP-49 and VAS scores across age, sex, time since overdenture insertion, mandibular dental status, smoking status, maxillary mucosal health, and overdenture hygiene. RESULTS: For the 44 participants, 3 of 4 implants failed in 1 individual. The cumulative implant survival rate was 98% (97.7% patient level). No prosthetic failures (that is, overdenture replacement) occurred, indicating a 100% prosthesis survival rate. The mean ±standard deviation OHIP-49 severity score was 23.6 ±26.0, and the mean ±standard deviation total VAS score was 179.2 ±29.4. Increased age was associated with lower OHIP-49 severity score (P=.036), and participants with unhealthy oral mucosa or denture stomatitis demonstrated significantly higher OHIP-49 severity scores (P=.003). CONCLUSIONS: In this retrospective evaluation, unsplinted implant-retained maxillary overdenture therapy was associated with high implant and prosthetic survival, as well as high patient satisfaction and quality of life. Age, sex, maxillary mucosal health, and mandibular dental status resulted in significant differences with respect to oral health-related quality of life and patient satisfaction, indicating that this treatment option may be ideal for certain patients.